CS DIAGNOSTICS CORP.
CSDX
—
Price unavailable
5
Visible periods
14
Metrics
Peer-ranked
Benchmarks
Price Chart
insights
Verdict pending
Sync financial data to generate a health grade for this company.
auto_awesome
Analytical Summary
Review the statement evidence below to form a view on CSDX.
Market Cap
—
Dividend Yield
—
Revenue Growth
189.4%
Op. Margin
-0.8%
ROIC
-0.0%
FCF / Share
—
Trailing P/E
—
Price / Book
—
FCF Yield
—
Debt / Equity
—
info
Valuation on last close.
5-Year Financial Trajectory
Quarterly
Metric
Value
Trend
Year over Year
Percentile
Revenue
Total top-line sales
$23.05K
Net Income
Profit after all expenses
$-182.00
Operating Margin
Operating profit as % of sales
-0.8%
Financial view
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
Is growth accelerating?
1 metrics
Are margins durable?
2 metrics
| Metric | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ | Q3 FY2024 Dec 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-Q ↗ |
|---|---|---|---|---|---|
| Operating Margin (%) (%) |
-0.8%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-107%)
|
— | — |
6.7%
Caution
Caution
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-44%)
|
— |
| Profit Margin (%) (%) |
-0.8%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-110%)
|
— | — |
6.7%
Caution
Caution
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-16%)
|
— |
Is capital allocation efficient?
3 metrics
| Metric | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ | Q3 FY2024 Dec 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-Q ↗ |
|---|---|---|---|---|---|
| Return on Invested Capital (%) |
-0.0%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — | — | — |
| Return on Capital (%) (%) |
-0.0%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — | — |
| Return on Common Equity (%) (%) |
-0.0%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-100%)
|
— | — | — | — |
How resilient is the balance sheet?
1 metrics
⌨️ Keyboard Shortcuts
/ Search
Esc Clear
A Annual
Q Quarterly
1-7 Jump to category
R Reset
Secondary lens
Benchmark Lens
Compare CSDX against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare CSDX against peers after checking the statement evidence.
Compare CSDX with peers
Stack CSDX against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago